mAbxience

mAbxience is a Spanish-based biopharmaceutical company founded in 2009. The company's slogan "From lab to life" reflects its core mission of providing accessible and affordable medicines globally to enhance the quality of life. With over a decade of expertise, mAbxience has established a strong presence in over 100 markets and has a network of more than 30 partners. The company's dedication is evident through its robust pipeline with two market-approved products and a team of over 1,000 professionals. mAbxience's three multi-product facilities in Europe and South America have obtained GMP approval from esteemed regulatory bodies, including the FDA and EMA. Their specialization in Contract Development and Manufacturing Organization (CDMO) services utilizes advanced technology and innovative platforms to deliver integrated manufacturing solutions. Although there is no public information available about their last investment or the investors involved, mAbxience's strong positioning in the biopharma and biotechnology sectors showcases potential for sustained growth and impact in the global healthcare industry. For more insights into mAbxience, their biosimilars, and CDMO business, visit their website (www.mabxience.com).